等待开盘 05-20 09:30:00 美东时间
-1.660
-0.56%
今日重点评级关注:TD Cowen:维持Strive"买入"评级,目标价从28美元升至30美元;蒙特利尔银行:维持KinderCare Learning"跑赢大市"评级,目标价从4美元升至6美元
05-19 10:55
Morgan Stanley analyst Joseph Moore maintains MKS (NASDAQ:MKSI) with a Overweight and raises the price target from $354 to $374.
05-18 19:12
MKS Instruments (MKSI) declares $0.25/share quarterly dividend, in line with previous. Forward yield 0.31% Payable June 12; for shareholders of record June 3; ex-div June 3. See MKSI Dividend Scorecar...
05-12 21:03
MKS Inc. announced a quarterly cash dividend of $0.25 per share, payable on June 12, 2026, to shareholders of record as of June 3, 2026. Future dividend declarations and related dates are subject to the Board of Directors' determination.
05-12 13:00
今日重点评级关注:HC Wainwright & Co.:维持Artiva Biotherapeutics"买入"评级,目标价从15美元升至35美元;韦德布什:维持Cullinan Therapeutics"跑赢大市"评级,目标价从36美元升至37美元
05-11 15:43
MKS Inc. (NASDAQ: MKSI) announced that its CEO, John T.C. Lee, will participate in a fireside chat at JP Morgan’s Global Technology, Media & Communications Conference on May 18, 2026, at 8:25 a.m. EDT. A live webcast will be available on the company's Investor Relations website, with a replay option afterward. MKS provides enabling technologies for semiconductor manufacturing, electronics, and specialty industrial applications, addressing challen...
05-11 12:00
今日重点评级关注:Citizens:维持BioCryst制药"跑赢大市"评级,目标价从25美元升至28美元;富国银行:维持曼恩凯德生物医疗"超配"评级,目标价从8美元升至10美元
05-08 12:05
华盛资讯5月8日讯,MKS Inc.公布2026财年Q1业绩,公司Q1营收10.78亿美元,同比增长15.2%,归母净利润0.84亿美元,同比增长61.5%。
05-08 03:52
Needham analyst James Ricchiuti maintains MKS (NASDAQ:MKSI) with a Buy and raises the price target from $300 to $360.
05-08 03:13